The abstract is read at the publisher; the summary is JClub's.
EUVAS convened a multidisciplinary focus group to address variability in kidney endpoint definitions in ANCA-associated vasculitis, proposing standardized kidney endpoints after four meetings over two years.
- Why it matters: Kidney outcomes in AAV are measured inconsistently across clinical trials, leaving an unmet need for clear endpoints for daily care and new drug development.
- What they did: The group reviewed literature and discussed terminology and outcome relationships across active disease, response, refractory disease, remission/relapse, recovery, and kidney failure needing kidney replacement therapy.
- The result: They report current variability, provide an expert proposal plus a research agenda, and outline a future Delphi consensus strategy to standardize kidney endpoints.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.